The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
about
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitroThe stats are in: an update on statin use in COPDCigarette smoke increases BLT2 receptor functions in bronchial epithelial cells: in vitro and ex vivo evidenceSurfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot StudyPathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases.Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.PPARĪ³ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.Cytokine inhibition in the treatment of COPD.Sputum myeloperoxidase in chronic obstructive pulmonary disease.A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment.Significance of the microbiome in chronic obstructive pulmonary disease.Investigating activity in hospitalized patients with chronic obstructive pulmonary disease: a pilot study.Factors influencing airway inflammation in chronic obstructive pulmonary disease.Resolvins: natural agonists for resolution of pulmonary inflammation.Perilla frutescens leaf extract inhibits mite major allergen Der p 2-induced gene expression of pro-allergic and pro-inflammatory cytokines in human bronchial epithelial cell BEAS-2B.In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism.Chronic obstructive pulmonary disease * 12: New treatments for COPDRelationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysemaSputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8Exhaled leukotrienes and prostaglandins in COPD.Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitisExpression of ErbB receptors and mucins in the airways of long term current smokers.Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPDMeasurement of C-reactive protein, procalcitonin and neutrophil elastase in saliva of COPD patients and healthy controls: correlation to self-reported wellbeing parameters.Role of neutrophils in mucus hypersecretion in COPD and implications for therapy.Computational Identification of Mechanistic Factors That Determine the Timing and Intensity of the Inflammatory Response.Roflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary diseaseExhaled eicosanoids and biomarkers of oxidative stress in exacerbation of chronic obstructive pulmonary diseaseGene therapy for chronic obstructive pulmonary disease: twilight or triumph?Inflammatory cells in the airways in COPD.Innate immune activation in neutrophilic asthma and bronchiectasis.Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.COPD exacerbations . 2: aetiologyPulmonary biomarkers in chronic obstructive pulmonary disease.Emerging drugs for the treatment of chronic obstructive pulmonary disease.Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex.
P2860
Q24799057-C6E3E79A-FF8F-4025-B154-73364534C0D7Q26778906-9FBA4529-36E9-4FE7-AEBE-E854A4EBB424Q28284072-6E831F4A-55E9-4D8C-8F85-782D782A1BD5Q28396135-7BE95F38-CDE4-4563-82D2-61DF55C692F9Q30332571-8B38523B-9910-416C-91E6-7F9F746DC068Q30884939-9E814220-C9EE-41FD-8AAE-A4AD04CA7308Q33556872-38EF74ED-530B-4B94-9681-CA8EC5804892Q33568552-1EEA8164-47A5-4E3D-B3AA-5D339DD0DC27Q33592946-CE434507-7A61-415D-98FC-BDDB7842D40AQ33610745-2BF13105-520A-4BF5-8952-F96FC3279950Q33817613-5EA50301-A2D9-4BB1-80E5-4C075214CC92Q33965387-633FD9F6-44D3-400F-B3FB-B0F7672CEC2AQ34069584-204FA4FB-168F-4C24-B2F6-611A8D098A7EQ34448487-CCC826B6-B8FB-4DAC-B732-F030DBF8557FQ35035274-18F8761E-01D8-4D6C-9890-21C064EAE989Q35045796-ABA6905A-64E9-4EEC-B3D7-F0CF779C166FQ35208742-F821F08E-94DD-4CA9-B562-06B94A8B734BQ35534142-F03F1FCA-DD12-4F1D-B481-CFB09A8F9CCEQ35535122-7CA146D0-5684-427A-B46B-649B1CE919BDQ35535330-E5FF5B3F-CC62-4BB4-82C7-A61D019FDCEFQ35536034-1C6E2F8C-0656-456D-BC38-37B5298CDE04Q35536126-A3AAF15F-1CD4-4925-9B7E-3054327DC4F7Q35536390-259A693E-DA28-48CC-86C0-F417094F854DQ35537218-ADFDA19B-257D-4CF4-A5BA-8F1A2DCC599DQ35672964-F2BEDD4D-CA46-4C4C-AD86-F6FFA74EC9B1Q35818337-495BD913-A893-47EA-B71E-98E9942BB630Q35859983-DAF55666-3B78-4AA4-9E46-40C997B566D5Q35958704-84E63F60-072F-4DA6-8F84-817F6A828D9BQ35990445-0A92910B-58E6-450A-8466-8D8128F16CD1Q36099456-CDE886BF-CA38-4294-B9E3-06341A1EF2AEQ36203075-58B9F523-2C85-46F4-AD82-90A69C15A947Q36225599-5F9FF2A8-6A9C-4A06-91E4-2462377FBC18Q36305351-0589C9B9-7DDD-4393-A80F-3698A54BC9E3Q36376519-61A260C6-B32F-4DF7-AEDB-3166F5F31CB4Q36379352-22761918-E493-4DEF-9DB8-D5BF3F302325Q36414253-C5D3116F-F4E3-4616-9726-98C4F180A90BQ36429908-97FAA7E9-0527-4755-97AA-7CCEC1D04EBDQ36458412-6D2C667C-27DA-4DA7-95BA-571D1238CAE1Q36796418-9C8587B3-11B2-444C-ADBC-C90A4AC03AD6Q36862444-915F7F4C-0BDC-4470-B18F-65A43E675D85
P2860
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
description
1999 nĆ® lÅ«n-bĆ»n
@nan
1999幓ć®č«ę
@ja
1999幓å¦ęÆęē«
@wuu
1999幓å¦ęÆęē«
@zh-cn
1999幓å¦ęÆęē«
@zh-hans
1999幓å¦ęÆęē«
@zh-my
1999幓å¦ęÆęē«
@zh-sg
1999幓åøč”ęē«
@yue
1999幓åøč”ęē«
@zh
1999幓åøč”ęē«
@zh-hant
name
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
@en
type
label
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
@en
prefLabel
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
@en
P2093
P2860
P921
P1476
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.160.3.9901091
P407
P577
1999-09-01T00:00:00Z